Simethicone as Part of ERAS in Bariatric Surgery Patients

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-89
SponsorMadigan Army Medical Center

About this trial

By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery.

The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.

Eligibility criteria

Qualifiers

Foregut procedures

Disqualifiers

Non-foregut procedures

Allergy to simethicone

Pregnancy or breastfeeding

Minors under 18 years of age

Trial design

Treatments tested in this trial

  • Simethicone 80 MG
  • Placebo

Treatment groups

260 Participants
are divided into 2 treatment groups

Sponsors and collaborators